In last trading session, Jaguar Health Inc (NASDAQ:JAGX) saw 197.78 million shares changing hands with its beta currently measuring 1.30. Company’s recent per share price level of $0.08 trading at $0.01 or 15.97% at ring of the bell on the day assigns it a market valuation of $16.68M. That closing price of JAGX’s stock is at a discount of -1487.5% from its 52-week high price of $1.27 and is indicating a premium of 37.5% from its 52-week low price of $0.05. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 44.02 million shares which gives us an average trading volume of 30.69 million if we extend that period to 3-months.
Jaguar Health Inc (NASDAQ:JAGX) trade information
Upright in the green during last session for gaining 15.97%, in the last five days JAGX remained trading in the green while hitting it’s week-highest on Wednesday, 03/20/24 when the stock touched $0.08 price level, adding 19.92% to its value on the day. Jaguar Health Inc’s shares saw a change of -47.23% in year-to-date performance and have moved 11.44% in past 5-day. Jaguar Health Inc (NASDAQ:JAGX) showed a performance of 13.49% in past 30-days. Number of shares sold short was 4.89 million shares which calculate 0.26 days to cover the short interests.
Jaguar Health Inc (JAGX) estimates and forecasts
Statistics highlight that Jaguar Health Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -71.11% of value to its shares in past 6 months, showing an annual growth rate of 83.89% while that of industry is 11.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to fall -22.00% from the last financial year’s standing.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $2.61 million for the same. And 1 analysts are in estimates of company making revenue of $2.76 million in the next quarter that will end on Mar 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 80.25% during past 5 years.
JAGX Dividends
Jaguar Health Inc is more likely to be releasing its next quarterly report between March 22 and March 26 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Jaguar Health Inc (NASDAQ:JAGX)’s Major holders
Insiders are in possession of 13.24% of company’s total shares while institution are holding 2.03 percent of that, with stock having share float percentage of 2.34%. Investors also watch the number of corporate investors in a company very closely, which is 2.03% institutions for Jaguar Health Inc that are currently holding shares of the company. Geode Capital Management, LLC is the top institutional holder at JAGX for having 92333.0 shares of worth $47643.0. And as of Jun 29, 2023, it was holding 0.48% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group Inc, which was holding about 79565.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 0.42% of outstanding shares, having a total worth of $41055.0.
On the other hand, Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 79361.0 shares of worth $40950.0 or 0.42% of the total outstanding shares. The later fund manager was in possession of 2825.0 shares on May 30, 2023, making its stake of worth around $1875.0 in the company or a holder of 0.01% of company’s stock.
